Design and Evolution of Enzymes with Non-Canonical Catalytic Mechanisms
Lead Research Organisation:
University of Manchester
Department Name: Chemistry
Abstract
The ability to rationally design an enzyme for any desired transformation would have major impacts across the pharmaceutical and wider chemical sectors, leading to more efficient and sustainable synthetic routes to high value chemicals. The combination of computational enzyme design and directed evolution is currently the most attractive strategy to achieve this ambition. However, the limited range of functional groups presented by the genetic code (i.e. 20 amino acids) restricts the range of catalytic mechanisms which can be installed into designed active sites, thus severely limiting the repertoire of chemical transformations accessible.
Advanced protein engineering technologies available in our laboratory now allow us to install non-canonical 'chemically inspired' amino acids into enzyme active sites, thus greatly expanding upon the limited range of functionality accessible with Nature's genetically encoded residues. We have recently combined this genetic code expansion technology with computational enzyme design and laboratory evolution to create the first enzyme that operates via a non-canonical organocatalytic mechanism (Nature 2019, 570, 219). In this PhD studentship, we will now expand ambitiously upon this early success, to demonstrate that the integration of non-canonical amino acids into computational design and directed evolution workflows can lead to the creation of enzymes with novel catalytic mechanisms and new activities. The design of new functional amino acids will be inspired by small molecule organocatalysts which are able to promote a plethora of valuable transformations not observed in Nature. Our approach merges the complementary disciplines of organocatalysis and biocatalysis, combining the mechanistic and functional versatility of small molecule systems with the enormous rate accelerations and reaction selectivities achievable within evolvable protein scaffolds.
The project is firmly embedded at the interface of chemistry, biology and biophysics, a key driver for the BBSRC in the 'Exploiting new ways of working' agenda. It draws on key bioscience skills, including protein engineering, directed evolution and enzyme characterization, and specifically exploits a multi-disciplinary approach to the creation of enzymes with novel function, which is a major objective in the Industrial Biotechnology sector.
Advanced protein engineering technologies available in our laboratory now allow us to install non-canonical 'chemically inspired' amino acids into enzyme active sites, thus greatly expanding upon the limited range of functionality accessible with Nature's genetically encoded residues. We have recently combined this genetic code expansion technology with computational enzyme design and laboratory evolution to create the first enzyme that operates via a non-canonical organocatalytic mechanism (Nature 2019, 570, 219). In this PhD studentship, we will now expand ambitiously upon this early success, to demonstrate that the integration of non-canonical amino acids into computational design and directed evolution workflows can lead to the creation of enzymes with novel catalytic mechanisms and new activities. The design of new functional amino acids will be inspired by small molecule organocatalysts which are able to promote a plethora of valuable transformations not observed in Nature. Our approach merges the complementary disciplines of organocatalysis and biocatalysis, combining the mechanistic and functional versatility of small molecule systems with the enormous rate accelerations and reaction selectivities achievable within evolvable protein scaffolds.
The project is firmly embedded at the interface of chemistry, biology and biophysics, a key driver for the BBSRC in the 'Exploiting new ways of working' agenda. It draws on key bioscience skills, including protein engineering, directed evolution and enzyme characterization, and specifically exploits a multi-disciplinary approach to the creation of enzymes with novel function, which is a major objective in the Industrial Biotechnology sector.
Organisations
People |
ORCID iD |
| Zachary Price (Student) |
Publications
Birch-Price Z
(2023)
Engineering enzyme activity using an expanded amino acid alphabet.
in Protein engineering, design & selection : PEDS
Birch-Price Z
(2024)
Noncanonical Amino Acids in Biocatalysis
in Chemical Reviews
Hutton AE
(2024)
A non-canonical nucleophile unlocks a new mechanistic pathway in a designed enzyme.
in Nature communications
Studentship Projects
| Project Reference | Relationship | Related To | Start | End | Student Name |
|---|---|---|---|---|---|
| BB/T008725/1 | 30/09/2020 | 29/09/2028 | |||
| 2449667 | Studentship | BB/T008725/1 | 30/09/2020 | 29/09/2024 | Zachary Price |
| Description | The primary aim of this studentship was to integrate non-canonical amino acids into directed evolution workflows, leading to the creation of enzymes with novel catalytic mechanisms and new activities. This aim was achieved through the discovery, characterisation and engineering of novel allylic transferase activity within computationally designed enzymes. This work has generated a new family of enzymes featuring a non-canonical amino acid that can catalyse a wide range of C-C and C-N bond formations in a stereocontrolled fashion, which will be of synthetic utility for the sustainable manufacture of pharmaceuticals and other fine chemicals. In addition to biochemical and structural information about the new enzymes, a rapid colourimetric assay was developed that enables high-throughput screening of reactants and enzyme variants to identify promising areas of chemical and sequence space. |
| Exploitation Route | These newly-developed allylic transferases may be applied by synthetic chemists and biotechnologists in academia and industry to produce valuable chiral molecules for a variety of purposes. In addition, enzyme engineers may take inspiration from the integration of non-canonical amino acids into directed evolution workflows to engineer a wide variety of industrially-relevant biocatalysts with enhanced properties. |
| Sectors | Chemicals Manufacturing including Industrial Biotechology Pharmaceuticals and Medical Biotechnology |